[New quinolones for the treatment of community-acquired pneumonia--pro].
Zimmerli
S
S
Institut für Infektionskrankheiten, Universität Bern. stefan.zimmerli@ifik.unibe.ch
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D006801:Humans; D008168:Lung / Q000378:metabolism; D008826:Microbial Sensitivity Tests; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D016896:Treatment Outcome
D042462:4-Quinolones; D000890:Anti-Infective Agents